New combo therapy trial aims to control advanced lung cancer
NCT ID NCT03141359
Summary
This study is testing a multi-step treatment for people with stage II or III non-small cell lung cancer. It combines precise, high-dose radiation to the main tumor with standard chemotherapy and radiation to nearby lymph nodes, followed by an immunotherapy drug. The main goal is to see if this approach helps keep the cancer from growing or spreading for at least one year after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
Conditions
Explore the condition pages connected to this study.